Codexis Inc. diskutieren
Codexis Inc.
WKN: A0Q2S4 / Symbol: CDXS / Name: Codexis / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
1,91 €
-1,75 %
Buy Codexis Inc.
Codexis, Inc. (NASDAQ: CDXS) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $6.00 price target on the stock.
Ratings data for CDXS provided by MarketBeat
Codexis, Inc. (NASDAQ: CDXS) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for CDXS provided by MarketBeat
Codexis, Inc. (NASDAQ: CDXS) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $9.00 price target on the stock.
Ratings data for CDXS provided by MarketBeat
Codexis, Inc. (NASDAQ: CDXS) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for CDXS provided by MarketBeat
Codexis, Inc. (NASDAQ: CDXS) had its price target lowered by analysts at Piper Sandler from $14.00 to $10.00. They now have an "overweight" rating on the stock.
Ratings data for CDXS provided by MarketBeat
Codexis, Inc. (NASDAQ: CDXS) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating.
Ratings data for CDXS provided by MarketBeat
Codexis, Inc. (NASDAQ: CDXS) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $9.00 price target on the stock.
Ratings data for CDXS provided by MarketBeat
Codexis, Inc. (NASDAQ: CDXS) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $11.00 price target on the stock.
Ratings data for CDXS provided by MarketBeat
Codexis, Inc. (NASDAQ: CDXS) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $5.00 price target on the stock.
Ratings data for CDXS provided by MarketBeat
Codexis, Inc. (NASDAQ: CDXS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $11.00 price target on the stock.
Ratings data for CDXS provided by MarketBeat
Codexis, Inc. (NASDAQ: CDXS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $11.00 price target on the stock.
Ratings data for CDXS provided by MarketBeat
Codexis, Inc. (NASDAQ: CDXS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $11.00 price target on the stock.
Ratings data for CDXS provided by MarketBeat
Codexis, Inc. (NASDAQ: CDXS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $11.00 price target on the stock.
Ratings data for CDXS provided by MarketBeat
Codexis, Inc. (NASDAQ: CDXS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $11.00 price target on the stock.
Ratings data for CDXS provided by MarketBeat
Codexis, Inc. (NASDAQ: CDXS) was upgraded by analysts at StockNews.com to a "sell" rating.
Ratings data for CDXS provided by MarketBeat
Codexis (CDXS) had its "overweight" rating reaffirmed by Cantor Fitzgerald.
Ratings data for CDXS provided by MarketBeat
Neueste Beiträge
Mizuho in Discuss MannKind Corp.